Warenkorb -  AGBs -  Datenschutz -  Contact us   

Psychiatry and Heart Disease: Mind, Brain and Heart


RIBA / WULSIN / RUBENFIRE  

Psychiatry and Heart Disease: Mind, Brain and Heart

272 Seiten, 1. Auflage, 2011

This unique book will help psychiatrists to understand better the risks of cardiovascular illness and cardiologists to appreciate possible pathophysiological links with psychiatric conditions.

It describes the common psychiatric conditions, their key features and how they may influence cardiovascular disease, outcomes, and quality of life. It also considers the cardiovascular complications that may arise as a result of mental illness.

In an exciting, collaborative approach, psychiatrists and cardiologists combine their expertise throughout the book to provide guidance on the best way to manage such patients, considering the patient as a whole, not the individual conditions.

Table of Contents
  • List of Contributors, vii
  • Foreword, xiKim A. Eagle, MD
  • Preface, xii
    Lawson Wulsin, MD, Michelle B. Riba, MD, MS, Melvyn Rubenfire, MD and Divy Ravindranath, MD, MS
  • 1 The Interaction Between Psychologic Distress and Biobehavioral Processes in Cardiovascular Disease, 1
    Willem J. Kop, PhD and John S. Gottdiener, MD
  • 2 Depression and Cardiovascular Diseases, 18
    Kevin B. Kerber, MD and Melvyn Rubenfire, MD
  • 3 Depression, Anxiety, Anger, and Heart Failure, 34
    Oliver G. Cameron, MD,PhD, Daniel Ehrmann and Bertram Pitt, MD
  • 4 Cardiac Surgery, 49
    Rima Styra, MD, Med, FRCPC, Christopher M. Feindel, MD and Marion E. McRae, RN, NP, MScN, CCRN-CSC-CMC, CCN, ACNP-BC
  • 5 Cardiac Transplantation and Left Ventricular Assist Devices: Pre-Assessment and Post-Management, 62
  • Rachel Lipson Glick, MD, David Bradley S. Dyke, MD, Moira Kessler, BS, MD and Dayna J. LePlatte, MD
  • 6 Psychiatric Aspects of Sudden Cardiac Arrest and Implantable Cardioverter-Defibrillators, 77 Divy Ravindranath, MD, MS and Frank Pelosi, MD
  • 7 Pulmonary Arterial Hypertension: Psychosocial Implications and Treatment, 88
    John M. Wryobeck, PhD and Melvyn Rubenfire, MD
  • 8 Distinguishing Cardiac from Psychologic Somatic Symptoms, 99
  • Nicholas D. Giardino, PhD and Michael J. Shea, MD
  • 9 Hypertrophic Cardiomopathy, 106
    Moira Kessler, BS, MD, Sara Saberi, MD, Sharlene Day, MD, Tamara Gay, MD, Linda Baty, BSN and Edward Deneke, MD
  • 10 Bipolar Disorder and Reducing Risk for Cardiovascular Disease, 116
  • Amy M. Kilbourne, PhD, MPH and David E. Goodrich, EdD
  • 11 Sleep and Cardiovascular Disease, 135 Sanjaya Gupta, MD and J. Todd Arnedt, PhD
  • 12 Posttraumatic Stress Disorder and Heart Disease, 153 Leonard A. Doerfler, PhD and John A. Paraskos, MD
  • 13 Cardiovascular Manifestations of Panic and Anxiety, 165
    Steven M. Schwartz, PhD, Oliver G. Cameron, MD, PhD and Melvyn Rubenfire, MD
  • 14 Genetic Susceptibility and the Relationship between Cardiovascular Disease, Immunology, and Psychiatric Illness, 176
    Sandra Villafuerte, PhD, Melvyn Rubenfire, MD and Ziad Kronfol, MD
  • 15 Psychological Symptoms Associated with Cardiovascular Drugs; Cardiac Symptoms from Psychiatric Drugs; Drug Interactions, 194
    Steven R. Erickson, Pharm D, Jolene R. Bostwick, Pharm D and Sally K. Guthrie, Pharm D
  • 16 Exercise and Depression, 211
  • Barry A. Franklin, PhD, Justin E. Trivax, MD and Thomas E. Vanhecke, MD
  • 17 Psychosocial Interventions: Meditation, 223
    Elizabeth A.R. Robinson, PhD, MSW, MPH, Sandra M. Finkel, MPH and Elizabeth A. Jackson, MD, MPH
  • 18 Smoking Cessation and Substance Use Modification in Cardiovascular Disease, 232
    Gregory W. Dalack, MD and Elizabeth A. Jackson, MD, MPH
Appendix A: Selected Screening Tools and Research Instruments, 241

Appendix B: Berlin Questionnaire (for sleep apnea), 247

Index, 249

ca. € 89,90
   
versandkostenfrei - in 8 bis 14 Werktagen lieferbar Anzahl:
Preis: ca. € 89,90